Peter Zannikos
Johnson & Johnson (United States)(US)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Lung Cancer Treatments and Mutations, Epilepsy research and treatment, Treatment of Major Depression, Pharmacological Effects and Toxicity Studies
Most-Cited Works
- → Phase I Trial and Pharmacokinetic Study of the Farnesyltransferase Inhibitor Tipifarnib in Children With Refractory Solid Tumors or Neurofibromatosis Type I and Plexiform Neurofibromas(2006)145 cited
- → Pharmacokinetic and pharmacodynamic study of two doses of bortezomib in patients with relapsed multiple myeloma(2010)106 cited
- → The effect of fluconazole on the clinical pharmacokinetics of methadone*(1998)98 cited
- → Effect of intranasal esketamine on cognitive functioning in healthy participants: a randomized, double-blind, placebo-controlled study(2018)71 cited
- → Validation and application of an LC–MS/MS method for quantitation of three fatty acid ethanolamides as biomarkers for fatty acid hydrolase inhibition in human plasma(2010)71 cited
- → Population Pharmacokinetics of Esketamine Nasal Spray and its Metabolite Noresketamine in Healthy Subjects and Patients with Treatment-Resistant Depression(2020)70 cited